BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1001 related articles for article (PubMed ID: 7760005)

  • 1. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
    Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
    J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
    de Paulis A; Ciccarelli A; de Crescenzo G; Cirillo R; Patella V; Marone G
    J Allergy Clin Immunol; 1996 Jul; 98(1):152-64. PubMed ID: 8765829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a 64-kd protein phosphorylated during chemotactic activation with IL-8 and fMLP of human polymorphonuclear leukocytes. I. Phosphorylation of a 64-kd protein and other proteins.
    Shibata M; Ohoka T; Mizuno S; Suzuki K
    J Leukoc Biol; 1993 Jul; 54(1):1-9. PubMed ID: 8393062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors.
    Fletcher MP; Stahl GL; Longhurst JC
    J Leukoc Biol; 1990 Apr; 47(4):355-65. PubMed ID: 2108228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Various authentic chemoattractants mediating leukocyte adherence inhibition.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered function and surface marker expression of neutrophils induced by rhG-CSF treatment in severe congenital neutropenia.
    Elsner J; Roesler J; Emmendörffer A; Zeidler C; Lohmann-Matthes ML; Welte K
    Eur J Haematol; 1992 Jan; 48(1):10-9. PubMed ID: 1370419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin regulates neutrophil migration in response to interleukin 8, leukotriene B4, tumor necrosis factor, and formyl-methionyl-leucyl-phenylalanine.
    Loike JD; el Khoury J; Cao L; Richards CP; Rascoff H; Mandeville JT; Maxfield FR; Silverstein SC
    J Exp Med; 1995 May; 181(5):1763-72. PubMed ID: 7722453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway.
    Cassatella MA; Bazzoni F; Ceska M; Ferro I; Baggiolini M; Berton G
    J Immunol; 1992 May; 148(10):3216-20. PubMed ID: 1578146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation.
    Sabroe I; Williams TJ; Hébert CA; Collins PD
    J Immunol; 1997 Feb; 158(3):1361-9. PubMed ID: 9013980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
    Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
    J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infiltrating neutrophils differ from circulating neutrophils when stimulated with C5a, NAP-1/IL-8, LTB4 and FMLP.
    Mrowietz U; Schröder JM; Brasch J; Christophers E
    Scand J Immunol; 1992 Jan; 35(1):71-8. PubMed ID: 1310358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
    Harvath L; McCall CE; Bass DA; McPhail LC
    J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C5a as a model for chemotactic factor-stimulated tyrosine phosphorylation in the human neutrophil.
    Richard S; Farrell CA; Shaw AS; Showell HJ; Connelly PA
    J Immunol; 1994 Mar; 152(5):2479-87. PubMed ID: 8133059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-operated activation of polymorphonuclear leukocytes: different effects of NAP-1/IL-8 and fMet-Leu-Phe or C5a.
    Wirthmueller U; Baggiolini M; de Weck AL; Dahinden CA
    Biochem Biophys Res Commun; 1991 May; 176(3):972-8. PubMed ID: 1645549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
    Kurrasch R; Elfman F; Perez HD
    J Immunol; 1989 Sep; 143(6):1969-73. PubMed ID: 2550548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.
    Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA
    Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins.
    Morita E; Schröder JM; Christophers E
    Scand J Immunol; 1989 Jun; 29(6):709-16. PubMed ID: 2544988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shedding of tumor necrosis factor receptors by activated human neutrophils.
    Porteu F; Nathan C
    J Exp Med; 1990 Aug; 172(2):599-607. PubMed ID: 2165128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An indirect bioluminescence method for the quantitative measurement of polymorphonuclear cell chemotaxis.
    Partsch G; Schwarzer C
    J Biolumin Chemilumin; 1991; 6(3):159-67. PubMed ID: 1660670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.